Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions

Go back to Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 13.56 +0.07 (0.52%)
Previous Close $13.49    52 Week High $135.54 
Open $13.39    52 Week Low $94.36 
Day High $13.60    P/E N/A 
Day Low $13.37    EPS $0.00 
Volume 285,511       

Bayer AG (AMEX: BAYZF) Delayed: 53.69 +0.89 (1.69%)
Previous Close $52.80    52 Week High $135.00 
Open $53.69    52 Week Low $94.95 
Day High $53.69    P/E N/A 
Day Low $53.69    EPS $0.00 
Volume 805